WallStreetZenWallStreetZen

NASDAQ: BIOL
Biolase Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

BIOL past revenue growth

How has BIOL's revenue growth performed historically?
Company
1.45%
Industry
9.39%
Market
17.61%
BIOL's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
BIOL's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
BIOL's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

BIOL earnings and revenue history

Current Revenue
$49.2M
Current Earnings
-$37.6M
Current Profit Margin
-76.5%

BIOL Return on Equity

Current Company
-1,012.4%
Current Industry
10.5%
Current Market
188%
BIOL's Return on Equity (-1,012.4%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when BIOL announces earnings.

BIOL Return on Assets

Current Company
-96.8%
Current Industry
5.3%
BIOL is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

BIOL Return on Capital Employed

Current Company
-118.15%
Current Industry
8.3%
BIOL's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

BIOL vs Medical Device Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
BIOL$49.16M-$15.44M-$37.62M+1.27%N/A
HSDT$644.00k-$8.89M-$8.85M+6.14%N/A
THMO$9.45M-$6.80M-$17.98M-0.47%N/A
AFIB$7.16M-$75.07M-$81.66M+27.03%N/A
VERO$76.35M-$26.31M-$37.25M-5.74%N/A
View Top Medical Device Stocks

BIOL earnings dates

Next earnings date
May 9, 2024

Biolase Earnings & Revenue FAQ

What were BIOL's earnings last quarter?

On Invalid Date, Biolase (NASDAQ: BIOL) reported Q4 2023 earnings per share (EPS) of -$7.16, up 94.51% year over year. Total Biolase earnings for the quarter were -$22.31 million. In the same quarter last year, Biolase's earnings per share (EPS) was -$130.40.

If you're new to stock investing, here's how to buy Biolase stock.

What was BIOL's earnings growth in the past year?

As of Q2 2024, Biolase's earnings has grown year over year. Biolase's earnings in the past year totalled -$37.62 million.

What is BIOL's earnings date?

Biolase's earnings date is Invalid Date. Add BIOL to your watchlist to be reminded of BIOL's next earnings announcement.

What was BIOL's revenue last quarter?

On Invalid Date, Biolase (NASDAQ: BIOL) reported Q4 2023 revenue of $13.49 million up 3.99% year over year. In the same quarter last year, Biolase's revenue was $14.05 million.

What was BIOL's revenue growth in the past year?

As of Q2 2024, Biolase's revenue has grown 1.45% year over year. This is 7.94 percentage points lower than the US Medical Devices industry revenue growth rate of 9.39%. Biolase's revenue in the past year totalled $49.16 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.